Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 6, Pages e2882
Publisher
Springer Nature
Online
2017-06-15
DOI
10.1038/cddis.2017.270
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global proteomic profiling identifies etoposide chemoresistance markers in non-small cell lung carcinoma
- (2016) Debasish Paul et al. Journal of Proteomics
- Atomic structure of the APC/C and its mechanism of protein ubiquitination
- (2015) Leifu Chang et al. NATURE
- Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68
- (2015) Kiran Kumar Nakka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cdc20 and securin overexpression predict short-term breast cancer survival
- (2014) H Karra et al. BRITISH JOURNAL OF CANCER
- SMAR1 coordinates HDAC6-induced deacetylation of Ku70 and dictates cell fate upon irradiation
- (2014) N Chaudhary et al. Cell Death & Disease
- High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma
- (2013) Inês M. B. Moura et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
- (2013) Wen-jing Wu et al. Journal of Translational Medicine
- High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer
- (2013) Jung-Woo Choi et al. VIRCHOWS ARCHIV
- Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
- (2012) Sadudee Chotirat et al. Journal of Hematology & Oncology
- Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients
- (2012) Tatsuya Kato et al. JOURNAL OF SURGICAL ONCOLOGY
- Identification and validation of genes involved in cervical tumourigenesis
- (2011) Thangarajan Rajkumar et al. BMC CANCER
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Mitotic Exit Leads to Tumor Regression In Vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ Phosphatase
- (2010) Eusebio Manchado et al. CANCER CELL
- Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element
- (2010) Surajit Sinha et al. EMBO JOURNAL
- F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage
- (2009) Manas K. Santra et al. NATURE
- Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20
- (2008) Gianluca Marucci et al. VIRCHOWS ARCHIV
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started